Literature DB >> 16697868

Triclosan loaded ureteral stents decrease proteus mirabilis 296 infection in a rabbit urinary tract infection model.

Peter A Cadieux1, Ben H Chew, Bodo E Knudsen, Kathy Dejong, Elaine Rowe, Gregor Reid, John D Denstedt.   

Abstract

PURPOSE: Infection and encrustation remain major limitations of ureteral stent use and to our knowledge no device has completely overcome these obstacles to date. Triclosan is a biocide currently used in a plethora of consumer and medical products that has recently been loaded into a ureteral stent. Using a rabbit model of UTI we examined the effects of triclosan impregnated stent segments on the growth and survival of Proteus mirabilis, a uropathogen commonly associated with device related UTI and encrustation.
MATERIALS AND METHODS: A total of 48 male New Zealand White rabbits were instilled transurethrally with 1 x 10(6) P. mirabilis 296. A stent curl from a triclosan eluting, Percuflex Plus or Optima ureteral stent was placed intravesically. Urine was cultured on days 1, 3 and 7. On day 7 the stents were assessed for encrustation and viable organisms, while the bladders were scored for the degree of inflammation.
RESULTS: Throughout the study urine isolated from the triclosan group contained significantly fewer viable organisms than controls with 7 of 13 animals completely clearing the infection by day 7. Similarly 9 of 13 triclosan eluting stents showed no viable organisms upon recovery and the remaining 4 showed significantly fewer organisms than controls. Urine and stents in all controls were positive for P. mirabilis at all time points. Although there was no significant difference in encrustation among the groups, bladders harvested from the triclosan group demonstrated significantly less inflammation.
CONCLUSIONS: Triclosan eluting stents greatly decreased P. mirabilis growth and survival in a rabbit UTI model compared to controls. These stents may prove useful for decreasing device related P. mirabilis UTIs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16697868     DOI: 10.1016/S0022-5347(06)00252-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  18 in total

Review 1.  Current status of ureteral stent technologies: comfort and antimicrobial resistance.

Authors:  Carlos E Mendez-Probst; Alfonso Fernandez; John D Denstedt
Journal:  Curr Urol Rep       Date:  2010-03       Impact factor: 3.092

2.  Update on ureteral stent technology.

Authors:  Dirk Lange; Ben H Chew
Journal:  Ther Adv Urol       Date:  2009-08

Review 3.  Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics.

Authors:  David Lebeaux; Jean-Marc Ghigo; Christophe Beloin
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

Review 4.  Update on biofilm infections in the urinary tract.

Authors:  Peter Tenke; Béla Köves; Károly Nagy; Scott J Hultgren; Werner Mendling; Björn Wullt; Magnus Grabe; Florian M E Wagenlehner; Mete Cek; Robert Pickard; Henry Botto; Kurt G Naber; Truls E Bjerklund Johansen
Journal:  World J Urol       Date:  2011-05-18       Impact factor: 4.226

Review 5.  Ureteral stent symptoms and associated infections: a biomaterials perspective.

Authors:  Ben H Chew; Dirk Lange
Journal:  Nat Rev Urol       Date:  2009-07-14       Impact factor: 14.432

6.  Enhanced antibacterial and anti-quorum sensing activities of triclosan by complexation with modified β-cyclodextrins.

Authors:  Marco Fidaleo; Antonio Zuorro; Roberto Lavecchia
Journal:  World J Microbiol Biotechnol       Date:  2013-03-28       Impact factor: 3.312

7.  Anti-adhesive coating and clearance of device associated uropathogenic Escherichia coli cystitis.

Authors:  Andrea Pechey; Chelsea N Elwood; Geoffrey R Wignall; Jeffrey L Dalsin; Bruce P Lee; Maaike Vanjecek; Ian Welch; Raymond Ko; Hassan Razvi; Peter A Cadieux
Journal:  J Urol       Date:  2009-08-15       Impact factor: 7.450

Review 8.  Engineering biomaterials to prevent post-operative infection and fibrosis.

Authors:  Aditya Josyula; Kunal S Parikh; Ian Pitha; Laura M Ensign
Journal:  Drug Deliv Transl Res       Date:  2021-03-12       Impact factor: 5.671

9.  Morbidity and impact on quality of life in patients with indwelling ureteral stents: A 10-year clinical experience.

Authors:  Ioan Scarneciu; Sorin Lupu; Catalin Pricop; Camelia Scarneciu
Journal:  Pak J Med Sci       Date:  2015       Impact factor: 1.088

10.  Ureteral stent discomfort: Etiology and management.

Authors:  Ricardo Miyaoka; Manoj Monga
Journal:  Indian J Urol       Date:  2009 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.